Results for “ ”

Entry Author Date Location
Regeneron Pays Intellia $100M to Add Hemophilia to CRISPR R&D Pact 06/01/20 New York
Forma Therapeutics Eyes IPO to Advance Sickle Cell, Prostate Cancer Drugs 05/29/20 Boston
After Inking Bristol Myers Pact, Repare Therapeutics Sets Sights on IPO 05/29/20 Boston
Bio Roundup: ASCO Opens, Merck Takes On COVID, Evofem’s Approval & More 05/29/20 National
New Webinars: In Vitro Hepatotoxicity Assessment Solutions & Enzyme Fragment Complementation Tech 05/27/20 Boston
COVID-19 Sparks New Opportunities for Digital Health Companies 05/26/20 Boston
Generation Bio Leads a Trio of Biotech Companies Aiming for the Nasdaq 05/22/20 National
Bio Roundup: mRNA Vaccine Data, Rise of Rallybio, Roche’s Protein Play & More 05/22/20 National
AMAG Pharma Sells Off Women’s Health Product in Planned Divestment 05/22/20 Boston
Sunovion Drug Gets FDA Nod for Treating Parkinson’s “Off” Episodes 05/21/20 Boston
HotSpot Therapeutics Adds $65M to Steer Allosteric Medicines to the Clinic 05/21/20 Boston
With $30M, Octant Launches Synthetic Bio Search for Multi-Target Drugs 05/20/20 San Francisco
Rallybio Lands $145M to Alter Course of FNAIT and More Rare Diseases 05/19/20 New York
Early COVID-19 Vaccine Data Sets Up Moderna for Next Stages of Testing 05/18/20 Boston
Deciphera Pharmaceuticals Wins Early FDA Nod for GI Cancer Treatment 05/15/20 Boston
Bio Roundup: FDA Dings BMS, Genfit’s Fall, Alexion’s Activist & More 05/15/20 National
Biotech “Mapmaker” Immunai Launches With $20M to Chart the Immune System 05/14/20 New York
QurAlis Hauls In $42M to Move New ALS Therapies Into Human Testing 05/13/20 Boston
Join us this Wednesday for Xcelerating Life Sciences: Biopharma’s Future in Digital Health 05/12/20 Boston
AMAG Pharma Cuts 140 Jobs Amid Restructuring, COVID-19 Disruptions 05/11/20 Boston
Dyno Debuts With Plan, Partnerships for Better Gene Therapy Vectors 05/11/20 Boston
Eli Lilly Gets Edge in the “RET” Race With FDA Nod for Cancer Drug 05/08/20 Indiana
Bio Roundup: Acquisitive Alexion, CRISPR on COVID, C. diff Success & More 05/08/20 National
PTC Therapeutics to Acquire Censa Pharma for Mid-Stage Rare Disease Drug 05/07/20 New York
Ventus Launches With $60M to Shine Light on Innate Immune System Drugs 05/06/20 Boston
Encouraging Signals for New Cancer Cell Therapy Strategies 05/06/20 National
Backed by $100M, Praxis Aims to Turn Epilepsy Research Into New Neuro Drugs 05/04/20 Boston
Lyra Therapeutics IPO Raises $56M for Tests of Tech for Runny Noses 05/01/20 Boston
Bio Roundup: Remdesivir Data, Erasca’s $200M, a New FDA Nod & More 05/01/20 National
Adicet Aims to Advance CAR-T Therapies in Reverse Merger with resTORbio 04/29/20 Boston
Page 1 of 632 next page »